Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells

Matrix Biology

Volumn 27, Issue 3, 2008, Pages 220-231

  Cortes Reynosa, Pedro ^a   Robledo, Teresa ^a   Macias Silva, Marina ^b   Wu, S Vincent ^c   Salazar, Eduardo Perez ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Basement membrane; Breast cancer; Collagen; FAK; MCF 7; MMP 9; Src

Indexed keywords

COLLAGEN TYPE 4; FAK KINASE; GELATINASE B; PROTEIN ANTIBODY; PROTEIN KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; ENZYME RELEASE; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; COLLAGEN TYPE IV; EXTRACELLULAR MATRIX; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; MODELS, BIOLOGICAL; NEOPLASMS; PHOSPHORYLATION; SRC-FAMILY KINASES; TIME FACTORS;

EID: 40649088574     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2007.11.003     Document Type: Article

References (88)

1. Acosta J.J., Munoz R.M., Gonzalez L., Subtil-Rodriguez A., Dominguez-Caceres M.A., Garcia-Martinez J.M., Calcabrini A., Lazaro-Trueba I., and Martin-Perez J. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol. Endocrinol. 17 (2003) 2268-2282
2. Agochiya M., Brunton V.G., Owens D.W., Parkinson E.K., Paraskeva C., Keith W.N., and Frame M.C. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 18 (1999) 5646-5653
3. Alford D., and Taylor-Papadimitriou J. Cell adhesion molecules in the normal and cancerous mammary gland. J. Mammary Gland. Biol. Neoplasia 1 (1996) 207-218
4. Aumailley M., and Gayraud B. Structure and biological activity of the extracellular matrix. J. Mol. Med. 76 (1998) 253-265
5. Avizienyte E., Wyke A.W., Jones R.J., McLean G.W., Westhoff M.A., Brunton V.G., and Frame M.C. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat. Cell Biol. 4 (2002) 632-638
6. Baciu P.C., Suleiman E.A., Deryugina E.I., and Strongin A.Y. Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-alphav integrin regulates cross-talk between alphavbeta3 and alpha2beta1 integrins in breast carcinoma cells. Exp. Cell Res. 291 (2003) 167-175
7. Bartsch J.E., Staren E.D., and Appert H.E. Matrix metalloproteinase expression in breast cancer. J. Surg. Res. 110 (2003) 383-392
8. Benaud C., Dickson R.B., and Thompson E.W. Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Res. Treat. 50 (1998) 97-116
9. Blake R.A., Broome M.A., Liu X., Wu J., Gishizky M., Sun L., and Courtneidge S.A. SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell Biol. 20 (2000) 9018-9027
10. Bon G., Folgiero V., Bossi G., Felicioni L., Marchetti A., Sacchi A., and Falcioni R. Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. Clin. Cancer Res. 12 (2006) 3280-3287
11. Borrirukwanit K., Lafleur M.A., Mercuri F.A., Blick T., Price J.T., Fridman R., Pereira J.J., Leardkamonkarn V., and Thompson E.W. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells. Matrix Biol. 26 (2007) 291-305
12. Boudreau N., Sympson C.J., Werb Z., and Bissell M.J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267 (1995) 891-893
13. Brown M.T., and Cooper J.A. Regulation, substrates and functions of Src. Biochim. Biophys. Acta 1287 (1996) 121-149
14. Cance W.G., Harris J.E., Iacocca M.V., Roche E., Yang X., Chang J., Simkins S., and Xu L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin. Cancer Res. 6 (2000) 2417-2423
15. Charvat S., Chignol M.C., Souchier C., Le Griel C., Schmitt D., and Serres M. Cell migration and MMP-9 secretion are increased by epidermal growth factor in HaCaT-ras transfected cells. Exp. Dermatol. 7 (1998) 184-190
16. Chen J.M., Aimes R.T., Ward G.R., Youngleib G.L., and Quigley J.P. Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts. J. Biol. Chem. 266 (1991) 5113-5121
17. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295 (2002) 2387-2392
18. Curran S., and Murray G.I. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 189 (1999) 300-308
19. Curran S., and Murray G.I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer 36 (2000) 1621-1630
20. Deryugina E.I., Luo G.X., Reisfeld R.A., Bourdon M.A., and Strongin A. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res. 17 (1997) 3201-3210
21. Duffy M.J., Maguire T.M., Hill A., McDermott E., and O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2 (2000) 252-257
22. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
23. Folgueras A.R., Pendas A.M., Sanchez L.M., and Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int. J. Dev. Biol. 48 (2004) 411-424
24. Garbett E.A., Reed M.W., Stephenson T.J., and Brown N.J. Proteolysis in human breast cancer. Mol. Pathol. 53 (2000) 99-106
25. Gordon L.A., Mulligan K.T., Maxwell-Jones H., Adams M., Walker R.A., and Jones J.L. Breast cell invasive potential relates to the myoepithelial phenotype. Int. J. Cancer 106 (2003) 8-16
26. Gunwar S., Ballester F., Noelken M.E., Sado Y., Ninomiya Y., and Hudson B.G. Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J. Biol. Chem. 273 (1998) 8767-8775
27. Guy C.T., Muthuswamy S.K., Cardiff R.D., Soriano P., and Muller W.J. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 8 (1994) 23-32
28. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., and Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck-and FynT-dependent T cell activation. J. Biol. Chem. 271 (1996) 695-701
29. Heussen C., and Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102 (1980) 196-202
30. Hodgson L., Henderson A.J., and Dong C. Melanoma cell migration to type IV collagen requires activation of NF-kappaB. Oncogene 22 (2003) 98-108
31. Hong I.K., Jin Y.J., Byun H.J., Jeoung D.I., Kim Y.M., and Lee H. Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J. Biol. Chem. 281 (2006) 24279-24292
32. Hsia D.A., Mitra S.K., Hauck C.R., Streblow D.N., Nelson J.A., Ilic D., Huang S., Li E., Nemerow G.R., Leng J., Spencer K.S., Cheresh D.A., and Schlaepfer D.D. Differential regulation of cell motility and invasion by FAK. J. Cell Biol. 160 (2003) 753-767
33. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69 (1992) 11-25
34. Iwata H., Kobayashi S., Iwase H., Masaoka A., Fujimoto N., and Okada Y. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn. J. Cancer Res. 87 (1996) 602-611
35. Jones J.L., Glynn P., and Walker R.A. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J. Pathol. 189 (1999) 161-168
36. Juarez J., Clayman G., Nakajima M., Tanabe K.K., Saya H., Nicolson G.L., and Boyd D. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int. J. Cancer 55 (1993) 10-18
37. Kim M.S., Lee E.J., Kim H.R., and Moon A. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 63 (2003) 5454-5461
38. Kim J.H., Lee K.W., Lee M.W., Lee H.J., Kim S.H., and Surh Y.J. Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-kappaB as a potential molecular target. FEBS Lett. 580 (2006) 385-392
39. Kornberg L.J. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 20 (1998) 745-752
40. Kossakowska A.E., Huchcroft S.A., Urbanski S.J., and Edwards D.R. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br. J. Cancer 73 (1996) 1401-1408
41. Liotta L.A., and Kohn E.C. The microenvironment of the tumour-host interface. Nature 411 (2001) 375-379
42. Liotta L.A., Steeg P.S., and Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 (1991) 327-336
43. Maquoi E., Noel A., Frankenne F., Angliker H., Murphy G., and Foidart J.M. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett. 424 (1998) 262-266
44. McClay D.R., and Ettensohn C.A. Cell adhesion in morphogenesis. Annu. Rev. Cell Biol. 3 (1987) 319-345
45. McDonald J.A. Extracellular matrix assembly. Annu. Rev. Cell Biol. 4 (1988) 183-207
46. Mendes O., Kim H.T., and Stoica G. Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin. Exp. Metastasis 22 (2005) 237-246
47. Mercurio A.M., Bachelder R.E., Chung J., O'Connor K.L., Rabinovitz I., Shaw L.M., and Tani T. Integrin laminin receptors and breast carcinoma progression. J. Mammary Gland. Biol. Neoplasia 6 (2001) 299-309
48. Miles A.J., Skubitz A.P., Furcht L.T., and Fields G.B. Promotion of cell adhesion by single-stranded and triple-helical peptide models of basement membrane collagen alpha 1(IV)531-543. Evidence for conformationally dependent and conformationally independent type IV collagen cell adhesion sites. J. Biol. Chem. 269 (1994) 30939-30945
49. Miyamori H., Hasegawa K., Kim K.R., and Sato H. Expression of metastasis-associated mts1 gene is co-induced with membrane type-1 matrix metalloproteinase (MT1-MMP) during oncogenic transformation and tubular formation of Madin Darby canine kidney (MDCK) epithelial cells. Clin. Exp. Metastasis 18 (2000) 51-56
50. Mon N.N., Hasegawa H., Thant A.A., Huang P., Tanimura Y., Senga T., and Hamaguchi M. A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1. Cancer Res. 66 (2006) 6778-6784
51. Munoz M.L., Calderon J., and Rojkind M. The collagenase of Entamoeba histolytica. J. Exp. Med. 155 (1982) 42-51
52. Muschler J., Lochter A., Roskelley C.D., Yurchenco P., and Bissell M.J. Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol. Biol. Cell 10 (1999) 2817-2828
53. Noritake H., Miyamori H., Goto C., Seiki M., and Sato H. Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in metastatic MDCK cells transformed by v-src. Clin. Exp. Metastasis 17 (1999) 105-110
54. Ottenhoff-Kalff A.E., Rijksen G., van Beurden E.A., Hennipman A., Michels A.A., and Staal G.E. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res. 52 (1992) 4773-4778
55. Owens L.V., Xu L., Craven R.J., Dent G.A., Weiner T.M., Kornberg L., Liu E.T., and Cance W.G. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55 (1995) 2752-2755
56. Park M.J., Park I.C., Hur J.H., Rhee C.H., Choe T.B., Yi D.H., Hong S.I., and Lee S.H. Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells. Neurosci. Lett. 290 (2000) 201-204
57. Park H.B., Golubovskaya V., Xu L., Yang X., Lee J.W., Scully II S., Craven R.J., and Cance W.G. Activated Src increases adhesion, survival and alpha2-integrin expression in human breast cancer cells. Biochem J. 378 (2004) 559-567
58. Parsons J.T. Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteins. Curr. Opin. Cell Biol. 8 (1996) 146-152
59. Parsons J.T., Schaller M.D., Hildebrand J., Leu T.H., Richardson A., and Otey C. Focal adhesion kinase: structure and signalling. J. Cell Sci. Suppl. 18 (1994) 109-113
60. Pellikainen J.M., Ropponen K.M., Kataja V.V., Kellokoski J.K., Eskelinen M.J., and Kosma V.M. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin. Cancer Res. 10 (2004) 7621-7628
61. Richardson A., and Parsons J.T. Signal transduction through integrins: a central role for focal adhesion kinase?. Bioessays 17 (1995) 229-236
62. Robledo T., Arriaga-Pizano L., Lopez-Perez M., and Salazar E.P. Type IV collagen induces STAT5 activation in MCF7 human breast cancer cells. Matrix Biol. 24 (2005) 469-477
63. Ruest P.J., Roy S., Shi E., Mernaugh R.L., and Hanks S.K. Phosphospecific antibodies reveal focal adhesion kinase activation loop phosphorylation in nascent and mature focal adhesions and requirement for the autophosphorylation site. Cell Growth Differ. 11 (2000) 41-48
64. Salazar E.P., and Rozengurt E. Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397. J. Biol. Chem. 276 (2001) 17788-17795
65. Sanders M.A., and Basson M.D. Collagen IV-dependent ERK activation in human Caco-2 intestinal epithelial cells requires focal adhesion kinase. J. Biol. Chem. 275 (2000) 38040-38047
66. Santoro S.A., and Cunningham L.W. Platelet-collagen adhesion. Methods Enzymol. 82 Pt A (1982) 509-513
67. Sato H., Kita M., and Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268 (1993) 23460-23468
68. Schaller M.D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 1540 (2001) 1-21
69. Schaller M.D., Borgman C.A., and Parsons J.T. Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol. Cell Biol. 13 (1993) 785-791
70. Schlaepfer D.D., Hauck C.R., and Sieg D.J. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71 (1999) 435-478
71. Segarra M., Vilardell C., Matsumoto K., Esparza J., Lozano E., Serra-Pages C., Urbano-Marquez A., Yamada K.M., and Cid M.C. Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells. Faseb J. 19 (2005) 1875-1877
72. Simon C., Goepfert H., and Boyd D. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58 (1998) 1135-1139
73. Soini Y., Hurskainen T., Hoyhtya M., Oikarinen A., and Autio-Harmainen H. 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J. Histochem. Cytochem. 42 (1994) 945-951
74. Somiari S.B., Shriver C.D., Heckman C., Olsen C., Hu H., Jordan R., Arciero C., Russell S., Garguilo G., Hooke J., and Somiari R.I. Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett. 233 (2006) 98-107
75. Soule H.D., Maloney T.M., Wolman S.R., Peterson Jr. W.D., Brenz R., McGrath C.M., Russo J., Pauley R.J., Jones R.F., and Brooks S.C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50 (1990) 6075-6086
76. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
77. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
78. Thompson E.W., Newgreen D.F., and Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?. Cancer Res. 65 (2005) 5991-5995 discussion 5995
79. Timpl R., Oberbaumer I., von der Mark H., Bode W., Wick G., Weber S., and Engel J. Structure and biology of the globular domain of basement membrane type IV collagen. Ann. N. Y. Acad. Sci. 460 (1985) 58-72
80. Tzinia A.K., Kitsiou P.V., Talamagas A.A., Georgopoulos A., and Tsilibary E.C. Effects of collagen IV on neuroblastoma cell matrix-related functions. Exp. Cell Res. 274 (2002) 169-177
81. Vincent-Salomon A., and Thiery J.P. Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res. 5 (2003) 101-106
82. Vincenti M.P., Coon C.I., White L.A., Barchowsky A., and Brinckerhoff C.E. src-related tyrosine kinases regulate transcriptional activation of the interstitial collagenase gene, MMP-1, in interleukin-1-stimulated synovial fibroblasts. Arthritis Rheum. 39 (1996) 574-582
83. Vincenti M.P., Schroen D.J., Coon C.I., and Brinckerhoff C.E. V-src activation of the collagenase-1 (matrix metalloproteinase-1) promoter through PEA3 and STAT: requirement of extracellular signal-regulated kinases and inhibition by retinoic acid receptors. Mol. Carcinog. 21 (1998) 194-204
84. Wang F.M., Liu H.Q., Liu S.R., Tang S.P., Yang L., and Feng G.S. SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1beta in vivo and in vitro. Breast Cancer Res. Treat. 89 (2005) 5-14
85. Weaver V.M., Lelievre S., Lakins J.N., Chrenek M.A., Jones J.C., Giancotti F., Werb Z., and Bissell M.J. Beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2 (2002) 205-216
86. Wisdom Jr. B.J., Gunwar S., Hudson M.D., Noelken M.E., and Hudson B.G. Type IV collagen of Engelbreth-Holm-Swarm tumor matrix: identification of constituent chains. Connect Tissue Res. 27 (1992) 225-234
87. Yeatman T.J. A renaissance for SRC. Nat. Rev. Cancer 4 (2004) 470-480
88. Yoshinaga I.G., Vink J., Dekker S.K., Mihm Jr. M.C., and Byers H.R. Role of alpha 3 beta 1 and alpha 2 beta 1 integrins in melanoma cell migration. Melanoma Res. 3 (1993) 435-441